Editorial: Management of childhood asthma.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000336:Aerosols; D000367:Age Factors; D001249:Asthma / Q000188:drug therapy* / Q000517:prevention & control; D001507:Beclomethasone / Q000627:therapeutic use; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D006801:Humans; D019966:Substance-Related Disorders; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D013566:Sympathomimetics; D001507:Beclomethasone; D004205:Cromolyn Sodium